Noopept vs. Piracetam: Which is More Effective?
I recently stumbled upon a study comparing the effectiveness and safety of piracetam and noopept. Though the focus of the study was on each nootropic’s ability to treat cognitive disorders as opposed to cognitive enhancement in healthy people, it still provides an interesting look at which of the two is more useful.
The drugs faced off in two different groups of participants. One group was made up of patients with CNS diseases of vascular origin, while the other was made up of patients suffering from post-traumatic CNS disorders. Noopept was administered in three daily doses of 20 mg, while piracetam was administered in three daily doses of 1200 mg.
Noopept Proved to be Safer and More Effective than Piracetam
The study found that while both nootropics improved the condition of patients in the study, Noopept was more effective. Within the first week of treatment patients suffering from vascular CNS diseases began to show signs of improvement. These improvements were mild at first, but increased more and more with each week of treatment. Virtually all patients suffering from vascular CNS diseases benefited from treatment with Noopept. It was almost as effective at treating trauma induced CNS diseases as well.
While the study found that piracetam also helped, it showed Noopept as a clear winner. The study found a 95% probibility that patients suffering from CNS diseases of a vascular origin would have better results from treatment with noopept instead of piracetam. Similar results were noted for CNS diseases caused by trauma.
The study found that Noopept is also much less likely to produce adverse effects. 1.8 times less likely to be exact. While we can’t extrapolate the results of this study to say definitively that noopept is a better cognitive enhancer in healthy people, this plus mountains of anecdotal evidence seem to point that way.
Click here to read the abstract.